Research shows that people with primary biliary cholangitis have significantly lower folate levels than healthy people, and those with advanced disease have the lowest folate of all. According to Gram Research analysis, a 2026 study of 180 people found that folate deficiency appears to trigger abnormal activity in genes controlling immune function and metabolism. When combined with standard liver tests, folate measurements predicted advanced disease with 97% accuracy, suggesting folate may serve as a useful marker for disease severity.
Researchers discovered that people with primary biliary cholangitis (a rare liver disease) have significantly lower folate levels than healthy people, and those with worse disease have even lower folate. According to Gram Research analysis, a 2026 study of 180 people found that folate deficiency appears to trigger changes in genes that control immune function and metabolism. When doctors combined folate measurements with other liver tests, they could predict advanced disease with 97% accuracy. The findings suggest folate may play an important role in how this liver disease develops and progresses.
Key Statistics
A 2026 research article of 180 participants found that serum folate levels were significantly decreased in primary biliary cholangitis patients compared to healthy controls, with further reduction in late-stage disease (p < 0.05).
According to research reviewed by Gram, combining folate detection with direct bilirubin and liver stiffness measurement achieved 97.4% accuracy (AUC = 0.974) for identifying advanced primary biliary cholangitis in a 180-person study.
Genetic analysis in a 2026 study of 90 PBC patients identified dysregulation of five key genes (AHRR, MXD1, ARID3B, DECR2, and P2RY14) with expression patterns directly linked to folate status.
Transcriptome analysis in a 180-person study identified between 2,363 and 5,648 differentially expressed genes enriched in metabolism and immune pathways, with folate status influencing gene activity patterns.
The Quick Take
- What they studied: Whether low folate (a B vitamin) levels are connected to primary biliary cholangitis severity and how folate affects genes involved in the disease
- Who participated: 90 patients diagnosed with primary biliary cholangitis and 90 healthy people without the disease, all compared for folate levels and genetic activity
- Key finding: PBC patients had significantly lower folate than healthy controls, with the sickest patients having the lowest levels. Five specific genes showed abnormal activity linked to folate status
- What it means for you: A simple blood test measuring folate could help doctors predict how severe your liver disease might become. However, this is early research and folate testing isn’t yet standard care for this condition
The Research Details
Researchers measured folate levels in blood samples from 90 people with primary biliary cholangitis and 90 healthy volunteers. They then examined genetic activity in three groups: PBC patients with normal folate, PBC patients with low folate, and healthy controls. Using advanced genetic sequencing technology, they identified thousands of genes that behaved differently between groups. Finally, they confirmed that five specific genes showed abnormal protein levels in people with low folate.
This approach allowed scientists to connect a simple blood measurement (folate) to complex genetic changes happening inside cells. By studying genes and proteins together, they could understand not just that folate was low, but how that deficiency might actually cause disease progression.
The researchers also tested whether combining folate measurements with other standard liver tests could predict advanced disease better than any single test alone.
This research design is important because it bridges the gap between what we can measure in blood (folate levels) and what’s actually happening inside cells (gene activity). Many diseases have simple markers that doctors can test, but we don’t always understand why those markers matter. This study explains the biological mechanism, making folate a more meaningful diagnostic tool rather than just a number on a lab report.
The study included equal numbers of patients and healthy controls, reducing bias. Genetic findings were validated using a second independent method (ELISA), which strengthens confidence in the results. The sample size of 180 people is moderate but adequate for this type of research. Published in a peer-reviewed journal (Frontiers in Nutrition) adds credibility. However, this is a single study, so results need confirmation in other populations before changing clinical practice.
What the Results Show
Serum folate levels were significantly lower in all PBC patients compared to healthy controls. More importantly, patients with advanced (late-stage) disease had even lower folate than those with early-stage disease, showing a clear relationship between folate deficiency and disease severity.
Genetic analysis revealed that folate status influenced the activity of thousands of genes involved in metabolism and immune function. Five genes showed particularly strong abnormal patterns: AHRR, MXD1, ARID3B, DECR2, and P2RY14. These genes control how the immune system responds and how cells process nutrients.
When doctors combined folate measurements with two other standard liver tests (direct bilirubin and liver stiffness measurement), they could identify patients with advanced disease with 97.4% accuracy. This combination test performed better than any single measurement alone.
The gene expression patterns directly correlated with folate status, meaning patients with the lowest folate showed the most abnormal gene activity.
Folate levels were negatively correlated with multiple markers of liver damage, including ALT, AST, and GGT enzymes, as well as IgG antibody levels. This suggests folate deficiency is associated with more active liver inflammation. Liver stiffness measurement (a test for scarring) also correlated with low folate, indicating that folate deficiency may be linked to more advanced fibrosis.
This is among the first studies to directly link folate deficiency to primary biliary cholangitis severity through genetic mechanisms. Previous research recognized that PBC involves immune system dysfunction, but the specific role of folate in triggering gene changes is novel. The findings align with broader research showing folate’s importance in immune regulation and suggest PBC may be added to conditions where folate status matters clinically.
The study included only 90 PBC patients from what appears to be a single center, so results may not apply to all populations. The research is observational, meaning it shows correlation between folate and disease severity but cannot prove that low folate causes worse disease. The study doesn’t test whether giving folate supplements actually improves outcomes. Additionally, the specific genes identified need validation in larger, independent populations before clinical use.
The Bottom Line
Current evidence suggests monitoring folate levels in PBC patients may help predict disease progression, but folate supplementation for PBC is not yet recommended without further research. Patients with PBC should maintain adequate folate intake through diet (leafy greens, legumes, fortified grains) or supplementation as part of general nutritional support. Discuss folate testing with your hepatologist before making changes.
People diagnosed with primary biliary cholangitis should be aware of this research, as it may influence future diagnostic approaches. Hepatologists and gastroenterologists treating PBC should consider these findings when evaluating new biomarkers. People with family history of autoimmune liver disease may find this relevant for understanding disease mechanisms. This research is NOT yet applicable to the general population or people without PBC.
If folate supplementation were to be tested in future clinical trials, benefits would likely take weeks to months to appear, as gene expression changes occur gradually. However, no timeline can be given since folate treatment for PBC hasn’t been studied yet.
Frequently Asked Questions
What is the connection between folate and primary biliary cholangitis?
Research shows PBC patients have significantly lower folate levels than healthy people, with the sickest patients having the lowest folate. Low folate appears to trigger abnormal activity in genes that control immune function and metabolism, potentially worsening disease progression.
Can folate supplements treat primary biliary cholangitis?
This study shows folate deficiency is associated with PBC severity, but it doesn’t prove that folate supplements will improve the disease. No clinical trials have tested folate treatment for PBC yet. Always consult your hepatologist before starting supplements.
How accurate is folate testing for predicting PBC severity?
When folate measurement was combined with two other liver tests, doctors could identify advanced disease with 97% accuracy in this study. However, this is early research and needs confirmation in larger populations before becoming standard clinical practice.
Should I get my folate levels tested if I have PBC?
Discuss folate testing with your hepatologist. While this research suggests folate status may predict disease progression, testing isn’t yet standard care for PBC. Your doctor can determine if it’s appropriate for your individual situation.
What foods are high in folate for PBC patients?
Excellent folate sources include leafy greens (spinach, kale), legumes (lentils, chickpeas), asparagus, broccoli, and fortified grains. Maintaining adequate folate through diet is important for overall health, though it’s not yet proven to treat PBC specifically.
Want to Apply This Research?
- Track serum folate levels quarterly if your doctor orders them, noting the exact value (ng/mL) and date. Also track liver enzyme levels (ALT, AST, GGT) from regular blood work to correlate with folate trends over time.
- If you have PBC, increase dietary folate intake by adding more leafy greens (spinach, kale), legumes (lentils, chickpeas), and fortified grains. Log these foods in your nutrition tracker to ensure consistent intake. Discuss supplementation options with your doctor before starting any folate supplements.
- Create a health dashboard showing folate levels alongside liver function tests and liver stiffness measurements over 6-12 months. This personal tracking helps you and your doctor identify patterns and may reveal whether dietary changes or supplementation correlates with disease markers.
This research is preliminary and has not yet led to changes in standard PBC treatment. Folate testing and supplementation for primary biliary cholangitis should only be pursued under the guidance of a qualified hepatologist or gastroenterologist. This article is for educational purposes and should not replace professional medical advice. Do not start, stop, or change any medications or supplements without consulting your healthcare provider. If you have primary biliary cholangitis, work with your medical team to develop an appropriate treatment and monitoring plan based on your individual circumstances.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.